Thyroid hormone and cardiac regeneration: from Prometheus myth to reality
|
|
- Neil Quinn
- 5 years ago
- Views:
Transcription
1 Thyroid hormone and cardiac regeneration: from Prometheus myth to reality C. Pantos Unit of Cardiac Regeneration and Cardiopreservation - University of Athens
2 Regeneration : an old concept
3 Amphibian metamorphosis : TH dependent nature s model of regeneration Slack JM, 2007
4 Early developmental stages : A window for regeneration Mourouzis et al, J Thyroid Res, 2011
5 Thyroid hormone : the same player in development and stress response TRα TRα Endocr. Rev. 2010
6 T3 TRα1 Development T3 TRα1 Stress T3 TRα1 Pantos et al, Heart Fail Rev, 2010
7 T3 and cell differentiation Linnane A et al, Ann N Y Ac Sci,2006
8 T3 induced tissue formation Pantos s laboratory data Chattergoon et al, FASEB J, 2011
9 Post-ischaemic remodeling and TH signaling: potential mechanisms and physiological consequences A. Normal Heart B. Untreated neonatal cardiomyocytes Compensated phase ERK( ), mtor ( ) TRα1 ( ) Post-infarcted heart scar TRα1 Phenylephrine treated neonatal cardiomyocytes ERK pathway PE mtor pathway α1-adrenergic receptor Pathological Growth Severe hypertrophy with α-mhc ( ) β-mhc( ) EF% ( ) LOW T3 TRα1 PE Decompensated phase ERK( ), mtor ( ) TRα1 ( ) scar TRα1 ERK pathway mtor pathway α1-adrenergic receptor Hypothyroid phenotype No further increase in hypertrophy with α- MHC ( ) β- MHC( ) EF% ( ) TRα1 Pantos et al, Heart Fail Rev, 2010
10 PE modulates TRα1 cytoplasmicnuclear shuttling CONT CLEN PE Pantos et al, J Physiol Pharmacol, 2008
11 TR α1: a molecular switch for the conversion of pathological to physiological growth Pantos et al, J Physiol Pharmacol, 2008
12 TH can rebuild the injured myocardium T3 TREATMENT Pantos et al, Heart Fail Rev, 2010
13 Submitted TH effect on postischaemic cardiac remodeling is a dose dependent process
14 Submitted TH effect on postischaemic cardiac remodeling is a dose dependent process
15 Submitted Akt : a molecular threshold for the TH beneficial/detrimental effect
16 T3 is a critical determinant of recovery of cardiac function after AMI Pantos et al, Eur J Endocrinol, 2007 Pantos et al, Eur J Endocrinol, 2011
17 IERVASI G et al Circulation 2010 A journey of one thousand miles begins with a single step The THiRST STUDY Acute and long term effects of Thyroid Hormone Replacement therapy in patients with ST-Elevation Myocardial Infarction (STEMI) and borderline/reduced triiodothyronine levels Eudract n
18 The analogy of heart failure and cancer
19 TR expression is altered in high grade glioma tumors Liappas A et al, J Thyroid Res, 2011
20 T3 re-differentiates cancer cells Liappas A et al, J Thyr Res, 2011
21 T3 suppresses cell proliferation Liappas A et al, J Thyr Res, 2011
22 The thyroid hormone paradox : TH protects against ischaemia Cell differentiation and response to stress share common signaling pathways Pantos et al, Heart Fail Rev, 2010
23 TRα1 : relevance to acute TH reparative effect DV Cokkinos, C Pantos, G Heusch, H Taegtmeyer (Eds), Myocardial ischemia : From mechanisms to therapeutic potentials, Springer, 2006
24 Studies in Isolated rat heart model of ischaemia /reperfusion Apoptosis/necrosis Function Increased apoptosis (red) Decreased apoptosis
25 T3 limits reperfusion injury by suppressing the activation of the pro-apoptotic p38mapk B. Non-treated T3-treated Sub-epicardium A. mid-myocardium T3 (40μg/L) Sub-endocardium 30 min Ischemia 60 min Reperfusio n Pantos et al, Basic Res Cardiol, 2008
26 T3 induced cardioprotection is TRα1 dependent Pantos et al, Mol Cell Biochem, 2011
27 Clinical analogy : T3 in CABG limits peri-operative injury CARDIAC INDEX C. Troponin release Ranasinghe et al, Circulation, 2006
28 Mourouzis et al, J Thyroid Res, 2011 Towards a new paradigm of stress response and tissue repair
29 Conclusions TH : the same player in organ development and response to stress Fetal phenotype is reactivated after stress and seems to be a window for regeneration- TH is involved in the reactivation of fetal phenotype after myocardial ischaemia TH can regenerate the ischaemic myocardium by reactivating developmental gene programming TH is a determinant of functional recovery after AMI in patients Clinical trials are underway to test the regenerative/reparative effect of TH in pts Thyroid analogs ( TRα1 agonists) may constitute new pharmacologic agents for regenerative treatments
30 C Pantos I Mourouzis V Malliopoulou C Xinaris E Karamanoli I Paizis S Tzeis P Moraitis D Kokkinos K Markakis A Dimopoulos T Saranteas K Mourouzis N Tsagoulis N Thempeyioti K Sfakianoudis A Kokkinos F Perimenis D Spanou G Galanopoulos DV Cokkinos
31 Thank you for your Attention
32 TH in GABG : a meta analysis Kaptein et al, J Clin Endocrin Metab, 2010
33
34
35
Low T3 syndrome among patients with acute myocardial infarction
Cent. Eur. J. Med. 9(1) 2014 10-14 DOI: 10.2478/s11536-013-0230-1 Central European Journal of Medicine Low T3 syndrome among patients Review Article Edita Jankauskienė*, Jolanta-Justina Vaškelytė, Eglė
More informationIschemic preconditioning fails to confer additional protection against ischemia reperfusion injury in the hypothyroid rat heart.
Ischemic preconditioning fails to confer additional protection against ischemia reperfusion injury in the hypothyroid rat heart. Iordanis Mourouzis 1, Antonios Dimopoulos 1, Theodosios Saranteas 1, Nikolaos
More informationTHYROID HORMONE RECEPTOR α1: A SWITCH TO CARDIAC CELL METAMORPHOSIS?
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 28, 59, 2, 253 269 www.jpp.krakow.pl C. PANTOS 1, C. XINARIS 1, I. MOUROUZIS 1, P. RIMENIS 1, E. POLITI 1, D. SPANOU 1, D. V. COKKINOS 2 THYROID HORMONE RECEPTOR
More informationEuropean Journal of Endocrinology (2007) ISSN
European Journal of Endocrinology (27) 156 415 424 ISSN 84-4643 CLINICAL STUDY Time-dependent changes in the expression of thyroid hormone receptor a1 in the myocardium after acute myocardial infarction:
More informationE. Cervio, P. Danieli, C. Ciuffreda, F. Pisano, M. Roccio, M. Gnecchi. The authors have no financial disclosures to declare
16 th ISCT Annual Meeting SOLUBLE FACTORS RELEASED BY HUMAN MESENCHYMAL STEM CELLS OF FETAL ORIGIN LEAD TO CARDIOMYOCYTE PROTECTION THROUGH THE INHIBITION OF PRO-APOPTOTIC SIGNALING E. Cervio, P. Danieli,
More informationEffects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart
European Journal of Pharmacology 444 (2002) 191 196 www.elsevier.com/locate/ejphar Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the
More informationResearch Article Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines
SAGE-Hindawi Access to Research Thyroid Research Volume, Article ID 8565, 8 pages doi:.46//8565 Research Article Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines Liappas Alexandros,,
More informationMyocardial infarction
NEW CARDIAC MARKERS AND CARDIAC REGENERATION Päivi Lakkisto, MD, PhD Specialist in Clinical Chemistry Clinical lecturer University of Helsinki and HUSLAB Minerva Institute for Medical Research Myocardial
More informationThyroid disease and vascular risk
Clinical Medicine 2014 Vol 14, No 6: s1 s4 ENDOCRINOLOGY Thyroid disease and vascular risk Authors: Avais Jabbar, A Salman Razvi B ABSTRACT Subclinical hypothyroidism (SCH) is a common condition seen in
More informationParacrine Mechanisms in Adult Stem Cell Signaling and Therapy
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all
More informationProtein kinase A mediated stimulation of activating transcription factor 3 by hypertrophic stimuli in cardiomyocytes
Protein kinase A mediated stimulation of activating transcription factor 3 by hypertrophic stimuli in cardiomyocytes Elina Koivisto, MD, PhD Institute of Biomedicine, Department of Pharmacology and Toxicology
More informationReperfusion Injury: How Can We Reduce It?
MI/CAD: Practical Question in Management of AMI Patients Reperfusion Injury: How Can We Reduce It? Hyun-Jai Cho, M.D., Ph.D Cardiovascular Center & Department of Internal Medicine Seoul National University
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation
More informationIschemic Heart Failure
15 th Cardiology Congress of Northern Greece Thessaloniki, May 26-28, 2016 Ischemic Heart Failure Filippos Triposkiadis, MD, FESC, FACC Professor of Cardiology Director, Department of Cardiology Larissa
More informationשינויים מולקולאריים ומבניים באי ספיקת לב אפשרויות לטיפול עתידני
שינויים מולקולאריים ומבניים באי ספיקת לב אפשרויות לטיפול עתידני פרופ יהונתן ליאור 1 Braunwald s Heart Disease 8th Edition Chapter 21 Mechanisms of Cardiac Contraction and Relaxation Chapter 22 Pathophysiology
More informationJournal Club Semmler Lorenz
Beer et al. 2015 - Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration Journal Club 13.11.2017 1 Introduction to
More informationAvailable at the Registration Booth
Available at the Registration Booth Thyroid Optimization Ron Rothenberg MD The following potential conflict of interest relationships are germane to my presentation. Equipment: NA Speakers Bureau: NA Stock
More informationReview Article Thyroid Hormones and Peripheral Nerve Regeneration
Thyroid Research Volume 2013, Article ID 648395, 5 pages http://dx.doi.org/10.1155/2013/648395 Review Article Thyroid Hormones and Peripheral Nerve Regeneration Ioannis D. Papakostas and George A. Macheras
More informationBorja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Fundación Jiménez Díaz Hospital.
STEMI 1: Timing, Mechanical Type and Pharmacology of Reperfusion: The Three Main Challenges to Decrease Infarct Size and Increase Viability Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones
More informationChallenging Issues in Cardiac Biomarker interpretation. F. Nikaeen. MD interventional Cardiologist
Challenging Issues in Cardiac Biomarker interpretation F. Nikaeen. MD interventional Cardiologist Biomarkers Types of Troponin Troponin C Binds calcium Troponin I Binds actin Troponin T Binds tropomyosin
More information6. Lochner, A., Tromp, E., Mouton, R. Signal transduction in myocardial ischaemia and reperfusion. Mol Cell Biochem., 160/161: , 1996.
PUBLICATIONS IN PEER-REVIEWED JOURNALS: 1. Moolman, J.A., Genade, S., Tromp, E., Lochner, A. Ischaemic preconditioning: interaction with antiadrenergic interventions. J Mol Cell Cardiol 27(6): A161, June
More informationSean Davidson. The Hatter Cardiovascular Institute University College London, UK
Key pathways to ischemia-reperfusion injury Sean Davidson The Hatter Cardiovascular Institute University College London, UK Outline What is ischaemia-reperfusion injury? What causes ischaemia-reperfusion
More informationMaster Eudipharm 2012 Introductory Module, Principles of Discovery of Medicine and Development Planning. Nathan Mewton, MD, PhD. September 26 th 2012
Master Eudipharm 2012 Introductory Module, Principles of Discovery of Medicine and Development Planning * Nathan Mewton, MD, PhD. September 26 th 2012 *A little bit of History *Rabies a viral disease that
More informationPathophysiology of ischemia-reperfusion injury (and how to protect against it )
Pathophysiology of ischemia-reperfusion injury (and how to protect against it ) Dr Derek J Hausenloy Reader in Cardiovascular Medicine BHF Senior Clinical Research Fellow Honorary Consultant Cardiologist
More information12 Lead EKG Chapter 4 Worksheet
Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining
More informationEducation/Training: (Begin with entry into college and include postdoctoral training)
BIOGRAPHICAL SKETCH (PI) Name: Hideshi Okada Degree(s): M.D., Ph.D. Position/Title: Postdoctoral Fellow Education/Training: (Begin with entry into college and include postdoctoral training) Institution
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationIschemic Heart Failure
Kalymnos Days Hellenic Cardiological Society Kalymnos, June 11, 2016 Ischemic Heart Failure Filippos Triposkiadis, MD, FESC, FACC Professor of Cardiology Director, Department of Cardiology Larissa University
More informationBEER AND THE HEART: INSIGHTS ON THE EFFECTS ON ALCOHOLIC AND NON-ALCOHOLIC BEER
BEER AND THE HEART: INSIGHTS ON THE EFFECTS ON ALCOHOLIC AND NON-ALCOHOLIC BEER Lina Badimon Cardiovascular Research Center (CRC) CSIC-ICCC Barcelona 7 TH EUROPEAN BEER AND HEALTH SYMPOSIUM BRUSSELS -2014
More informationRegenerative Medicine for Cardiomyocytes
Regenerative Medicine Regenerative Medicine for JMAJ 47(7): 328 332, 2004 Keiichi FUKUDA Assistant Professor, Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine Abstract: Heart
More informationThe relationship of thyroid hormone status with myocardial function in stress cardiomyopathy
European Journal of Endocrinology (2009) 160 799 806 ISSN 0804-4643 CLINICAL STUDY The relationship of thyroid hormone status with myocardial function in stress cardiomyopathy Seong Jin Lee, Jun Goo Kang,
More informationAdipose Tissue Dysfunction and Diabetic Cardiovascular Disease
Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Xin-Liang Ma, MD, PhD Thomas Jefferson University Philadelphia, PA USA CVD As The #1 Causes of Death In USA Male Female Heart Disease and
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our
More informationDisclosures. Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin
Disclosures Speaker s bureau: Research grant: Advisory Board: Servier International, Bayer, Merck Serono, Novartis, Boehringer Ingelheim, Lupin Servier International, Boehringer Ingelheim Servier International,
More informationCKD Satellite Symposium
CKD Satellite Symposium Recommended Therapy by Heart Failure Stage AHA/ACC Task Force on Practice Guideline 2001 Natural History of Heart Failure Patients surviving % Mechanism of death Sudden death 40%
More informationA Low ft3 Level as a Prognostic Marker in Patients with Acute Myocardial Infarctions
ORIGINAL ARTICLE A Low ft3 Level as a Prognostic Marker in Patients with Acute Myocardial Infarctions Baowei Zhang, Wenhui Peng, Chaofan Wang, Weiming Li and Yawei Xu Abstract Objective To investigate
More informationRecovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment
2016 춘계심혈관통합학술대회, 경주 Recovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment Youngkeun Ahn, MD, PhD Department of Cardiology, Cardiovascular Center Chonnam National University
More informationMWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient
MWLCEMS SYSTEM Continuing Education Packet Management of the Acute MI Patient In this CE we will discuss the patient presenting with an acute ST-Elevation Myocardial Infarction (STEMI) Definition: Myocardial
More informationDISEASE ETIOLOGY. Dynamic condition Morpho-functional alteration of one or more organ/tissue Acute or chronic Localized or systemic
DISEASE Dynamic condition Morpho-functional alteration of one or more organ/tissue Acute or chronic Localized or systemic Etiology = studies the causes of disease Pathogenesis = starting from etiology,
More informationDr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK
Advanced heart failure - devices, mechanical circulatory support and cardiac transplantation Monday 30 January 2017 Stem cell and gene therapies for heart failure Dr. Alexander Lyon Senior Lecturer and
More information1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and
1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,
More informationPathophysiology of Coronary Microvascular Dysfunction
Pathophysiology of Coronary Microvascular Dysfunction Cheol Woong Yu, MD, PhD Cardiology Department Division of Internal Medicine Korea University Anam Hospital. Etiologies of Chest Pain without obstructive
More informationDr. Hany M. Abo-Haded
BY Dr. Hany M. Abo-Haded Pediatric Cardiology Unit, Mansoura Universty Children Hospital, Mansoura, Egypt Co-authors: Dina S El-Agamy and Mohamed A Elkablawy Background Doxorubicin (DOX) is an anthracycline
More informationIschemia and Reperfusion: Pharmacological treatment options
Physiologisches Institut Ischemia and Reperfusion: Pharmacological treatment options Prof. Dr. Rainer Schulz Plaque rupture and myocardial ischemia Acute plaque rupture (Stary VI) Ischemic myocardium (ACS,
More informationRationale for Prophylactic Support During Percutaneous Coronary Intervention
Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories
More informationExperimental Physiology
Exp Physiol 93.2 pp 237 246 237 Experimental Physiology Experimental hyperthyroidism increases expression of parathyroid hormone-related peptide and type-1 parathyroid hormone receptor in rat ventricular
More informationCell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory
Cell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory BANFF-SCT Joint Scientific Meeting 2017 Barcelona, 29 th March Santi Roura, PhD Grup ICREC IGTP HuGTiP (Badalona)
More informationSmall Platform Catheter-Based Left Ventricular Assist Device Support Suppresses Cardioprotective Beta Arrestin- Mediated Signal Transduction
Small Platform Catheter-Based Left Ventricular Assist Device Support Suppresses Cardioprotective Beta Arrestin- Mediated Signal Transduction Keshava Rajagopal, MD PhD, Progyaparamita Saha, PhD, Isa Mohammed,
More informationHeart failure (HF) is a major public health and economic
Contemporary Reviews in Cardiovascular Medicine Thyroid Replacement Therapy and Heart Failure Anthony Martin Gerdes, PhD; Giorgio Iervasi, MD Heart failure (HF) is a major public health and economic problem
More informationIschemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Phy
Ischemic Postconditioning During Primary Percutaneous Coronary Intervention Mechanisms and Clinical Application Jian Liu, MD FACC FESC FSCAI Chief Physician, Professor of Medicine Department of Cardiology,
More informationIschemic Heart Disease
Ischemic Heart Disease Dr Rodney Itaki Lecturer Division of Pathology University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Consideration Results from partial
More informationSupporting Information. Calculation of the relative contributions of myocyte proliferation, stem cell. Supporting Information Fig 1 (page 9)
Supporting Information Table of contents Calculation of the relative contributions of myocyte proliferation, stem cell differentiation and cardioprotection (page 2) Supporting Information Fig 1 (page 9)
More informationEffect of Fetal Hypothyroidism on Cardiac Myosin Heavy Chain Expression in Male Rats
Effect of Fetal Hypothyroidism on Cardiac Myosin Heavy Chain Expression in Male Rats Nasibeh Yousefzadeh 1, Sajad Jeddi 2, Mohammad Reza Alipour 1 Drug Applied Research Center, Tabriz University of Medical
More informationMyocardial lipid accumulation and lipotoxicity in heart failure
Myocardial lipid accumulation and lipotoxicity in heart failure P. Christian Schulze, MD, PhD New York - Presbyterian Hospital, Columbia University Medical Center, Division of Cardiology, New York, NY,
More informationBEDSIDE ASSESSMENT OF PATIENTS WITH STEMI
BEDSIDE ASSESSMENT OF PATIENTS WITH STEMI Prof. Maria Dorobantu, PhD, FESC, FACC Emergency Hospital of Bucharest, Romania Presenter Disclosures There are no conflicts/ grants/ disclosures for this presentation.
More informationLeft Main PCI vs. CABG: Real World
Management of Patients with Stable CAD Left Main PCI vs. CABG: Real World Marco Roffi, MD, FESC University Hospital Geneva, Switzerland SYNTAX-LMT The SYNTAX trial included a pre-specified subgroup of
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial
More informationCrosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea
Crosstalk between Adiponectin and IGF-IR in breast cancer Prof. Young Jin Suh Department of Surgery The Catholic University of Korea Obesity Chronic, multifactorial disorder Hypertrophy and hyperplasia
More informationcardiac pre and post conditioning
cardiac pre and post conditioning i Stefan De Hert Department of Anesthesiology University Hospital Ghent University of Ghent 2010 Universitair Ziekenhuis Gent Belgium = limited exposition to a small potential
More informationImaging and heart failure
Imaging and heart failure Jeroen J Bax Dept of Cardiology Leiden Univ Medical Center The Netherlands Davos, feb 2013 Research grants: Medtronic, Biotronik, Boston, St Jude, BMS imaging, GE Healthcare,
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationPathophysiology of heart failure with preserved ejection fraction. Extracellular matrix
Pathophysiology of heart failure with preserved ejection fraction Extracellular matrix Javier Díez, MD, PhD. Full Professor of Cardiovascular Medicine and Director Division of Cardiovascular Sciences Centre
More informationMesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future
Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem
More informationPrediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction
ORIGINAL ARTICLE Korean J Intern Med 2014;29:454-465 Prediction of infarct severity from triiodothyronine levels in patients with ST-elevation myocardial infarction Dong Hun Kim 1, Dong-Hyun Choi 2, Hyun-Wook
More informationMedical management of LV aneurysm and subsequent cardiac remodeling: is it enough? J. Parissis Attikon University Hospital Athens, Greece
Medical management of LV aneurysm and subsequent cardiac remodeling: is it enough? J. Parissis Attikon University Hospital Athens, Greece Disclosures Grants: ALARM investigator received research grants
More informationWhat about aborted infarction?
Unanswered Qs in STEMI management Q3 What about aborted infarction? Is there consensus on the definition? Aborted infarction and TIME to treatment Aborted MI as an outcome measure? Conclusions By Dr Jason
More informationA case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD
A case of post myocardial infarction ventricular septal rupture CHRISTOFOROS KOBOROZOS, MD NAVAL HOSPITAL OF ATHENS case presentation Female, 81yo Hx: diabetes mellitus, hypertension, chronic anaemia presented
More informationAcute coronary syndrome. Dr LM Murray Chemical Pathology Block SA
Acute coronary syndrome Dr LM Murray Chemical Pathology Block SA13-2014 Acute myocardial infarction (MI) MI is still the leading cause of death in many countries It is characterized by severe chest pain,
More informationCoronary Revascularization in Patients witj Severe LV Dysfunction.: Is the concept of viability still viable?
Coronary Revascularization in Patients witj Severe LV Dysfunction.: Implications of the STICH trial Is the concept of viability still viable? Banff 2016 3041435-1 Prognosis of Patients With LV Dysfunction
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationInternational Graduate Research Programme in Cardiovascular Science
1 International Graduate Research Programme in Cardiovascular Science This work has been supported by the European Community s Sixth Framework Programme under grant agreement n LSHM-CT-2005-01883 EUGeneHeart.
More informationPerioperative Infarcts: Epidemiology, predictors and post-op monitoring
Friday Nov 3rd, 2017 1pm Perioperative Infarcts: Epidemiology, predictors and post-op monitoring Dr Carol Chong Geriatrician Northern Health, Epping, Victoria, Australia How I became interested in this
More informationΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ. ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας
ΕΘΝΙΚΟ ΚΑΙ ΚΑΠΟΔΙΣΤΡΙΑΚΟ ΠΑΝΕΠΙΣΤΗΜΙΟ ΑΘΗΝΩΝ ΙΑΤΡΙΚΗ ΣΧΟΛΗ Ά ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Διευθυντής: Καθηγητής Δημήτριος Τούσουλης ΒΙΟΔΕΙΚΤΕΣ ΣΤΗΝ ΚΑΡΔΙΑΚΗ ΑΝΕΠΑΡΚΕΙΑ ΔΗΜΗΤΡΙΟΣ ΤΟΥΣΟΥΛΗΣ Καθηγητής Καρδιολογίας
More informationEuropean Society of Cardiology Congress DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS
European Society of Cardiology Congress 28 Aug - 01 Sep 2009, Stockholm - Sweden DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS Massimiliano
More informationThe role of mirnas in cardiac hypertrophy
The role of mirnas in cardiac hypertrophy Fabian Pruissen Biology of Disease 2011 Supervised by Sjoukje Lok, MD and Roel de Weger, PhD Abstract Cardiac hypertrophy and increased cardiomyocytes size are
More informationMR Assessment of Myocardial Viability
MR Assessment of Myocardial Viability Definition of Viability Clinical Metabolism: Presence of glucose uptake Perfusion / Perfusion reserve Morphology: Wall thickness, wall thickening Contractility: Recovery
More informationSTEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury.
STEMI: Evolving Early Therapies of Myocardial Ischemia/Reperfusion Injury. Borja Ibanez, MD PhD FESC. - Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC). - Hospital Clínico San Carlos.
More informationNew universal definition of myocardial infarction
New universal definition of myocardial infarction L. K. Michalis, ΜRCP, FESC Professor of Cardiology, University of Ioannina Changing Criteria for definition of MI Primarily clinical & ECG approach First
More informationRemodeling the failing heart: : the biology and future treatment options
Remodeling the failing heart: : the biology and future treatment options J-L Balligand (UCL-Brussels, BE) jl.balligand@uclouvain.be Myocardial remodeling: definitions phenotypic plasticity : remodeling
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationA Comparison of Different Doses of Dexmedetomidine for Myocardial Protection in Percutaneous Coronary Interventional Patients
A Comparison of Different Doses of Dexmedetomidine for Myocardial Protection in Percutaneous Coronary Interventional Patients Authors: *Tanveer Singh Kundra, 1 Poonugunta S. Nagaraja, 1 Parminder Kaur
More informationMesenchymal Stem Cells and Cancer: Their Interplay
Mesenchymal Stem Cells and Cancer: Their Interplay Gang Li, MBBS, DPhil (Oxon) Stem Cell and Regeneration Program School of Biomedical Sciences Li Ka Shing Institute of Health Sciences Department of Orthopaedics
More informationBiomarkers in cardiovascular disease. Felix J. Rogers, DO, FACOI April 29, 2018
Biomarkers in cardiovascular disease Felix J. Rogers, DO, FACOI April 29, 2018 Biomarkers NIH: A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biological
More informationDefinition of Congestive Heart Failure
Heart Failure Definition of Congestive Heart Failure A clinical syndrome of signs & symptoms resulting from the heart s inability to supply adequate tissue perfusion. CHF Epidemiology Affects 4.7 million
More information3/27/2014. Introduction.
Introduction. Myocardial perfusion & contractility becomes abnormal immediately after the onset of ischaemia, even before the development of the symptoms & ST segment changes. 1 Myocardial Wall Motion
More informationManagement of new-onset AF: Initial rate control treatment
Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,
More informationChronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute
Chronic Total Occlusions Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Financial Disclosures /see -tee-oh / abbr. Med. Chronic Total Occlusion,
More informationSecond Generation of Calcium Antagonists
Winifred G. Nayler Second Generation of Calcium Antagonists With 81 Figures and 63 Tables Springer-Verlag Berlin Heidelberg New York London Paris Tokyo Hong Kong Barcelona Budapest Contents Foreword Chapter
More informationΣεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική
ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL
More informationNNZ-2566 in Rett Syndrome and Autism Spectrum Disorders Role and Update
NNZ-2566 in Rett Syndrome and Autism Spectrum Disorders Role and Update 1 Overview The natural growth factor IGF-1 is broken down in the body to IGF-1[1-3] NNZ-2566 is an analogue of IGF-1[1-3] developed
More informationINNOVATION THAT REALLY MATTERS. Prof. Lina Badimon. Institut Català de Ciències Cardiovasculars (ICCC), Barcelona
INNOVATION THAT REALLY MATTERS Prof. Lina Badimon, Barcelona THE INSTITUTION THE INSTITUTION THE ICCC CATALAN INSTITUTE FOR CARDIOVASCULAR SCIENCE (ICCC) Objectives LEADING AN STRATEGIC PLANNING IN CVR
More informationDeposited on: 25 July 2011
Morton, E., Macrae, I.M., McCabe, C., Brown, S.M. and White, F. (2006) Identification of the growth arrest and DNA damage protein GADD34 in the normal human heart and demonstration of alterations in expression
More informationSTEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia.
STEMI Stents What next? Arshad Khan - HNE Clinical Research Fellow. Supervisors: Prof Boyle and Attia. PART 1 Systems of care for STEMI. STEMI Management Coronary angiogram +/- stenting. Prehospital thrombolysis
More informationHigh-Sensitive Troponin in the Evaluation of patients with Acute Coronary Syndrome (High-STEACS): a stepped-wedge cluster-randomised controlled trial
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2018 High-Sensitive Troponin in the Evaluation of patients with Acute Coronary Syndrome (High-STEACS): a stepped-wedge cluster-randomised controlled trial Professor
More informationLong-Term Management: Preventing Progression. Daniel Burkhoff Cardiovascular Research Foundation and Columbia University
Long-Term Management: Preventing Progression Daniel Burkhoff Cardiovascular Research Foundation and Columbia University Disclosure Unrestricted institutional (CRF) educational grant from Abiomed Left Ventricular
More informationDiastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure
Diastolic Dysfunction: Hypertension to Hypertrophy to Heart Failure Dr. Shelley Zieroth FRCPC Assistant Professor, Cardiology, University of Manitoba Director of Cardiac Transplant and Heart Failure Clinics
More informationMammalian Fetal Cardiac Regeneration After Myocardial Infarction Is Associated With Differential Gene Expression Compared With the Adult
Mammalian Fetal Cardiac Regeneration After Myocardial Infarction Is Associated With Differential Gene Expression Compared With the Adult Carlos Zgheib, PhD,* Myron W. Allukian, MD,* Junwang Xu, PhD, Michael
More informationRational use of imaging for viability evaluation
EUROECHO and other imaging modalities 2011 Rational use of imaging for viability evaluation Luc A. Pierard, MD, PhD, FESC, FACC Professor of Medicine Head, Department of Cardiology, CHU Liège, Belgium
More informationIschemic Mitral Valve Disease: Repair, Replace or Ignore?
Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship
More informationCNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa
CNR, G. Monasterio Foundation, Clinical Physiology Institute Pisa Stockholm Aug 29, 2010 Role of MRI in the acute Myocardial Infarction? massimo lombardi Two days after infarct (top row), the T2 hyperintense
More information